Severe COPD Exacerbators Requiring Multiple ICU Admissions Over Time: Insights of a French Cohort
Abstract
Introduction: Data on COPD patients who experience multiple intensive care unit (ICU) admissions for severe acute exacerbations (AECOPD) are scarce. We aimed to describe and compare patients' characteristics by recurrent admission status and to identify factors associated with recurrent ICU-level exacerbations. Methods: We conducted a single-centre, retrospective cohort study including all patients admitted to our ICU between 2015 and 2022 for a severe AECOPD. Patients with more than one ICU admission during the study period were classified as "recurrent exacerbator" phenotype. Multivariable regression and competing-risk models were used. Results: We included 328 patients who had a total of 445 admissions. Seventy-two (22.0%) patients had multiple ICU admissions. Compared with non-recurrent patients, recurrent exacerbators were younger (median 67 vs 70 years, p=0.037), had a lower prevalence of impaired Performance Status (13.9% vs 25.8%, p=0.035), and had higher blood eosinophil counts (0.06 vs 0.04 G/L, p=0.025). One-year mortality was similar between groups (18.1% vs 18.4%, p=0.95). In multivariate model, factors independently associated with recurrent severe exacerbation were long-term oxygen therapy (HR = 1.79, p=0.045) and initial blood eosinophil count (HR per +0.1 G/L = 1.10, p<0.001). A Performance Status ≥3 was inversely associated with recurrence (HR per point = 0.41, p=0.030). Conclusion: Patients with recurrent ICU admission for severe COPD exacerbations were younger and had higher blood eosinophil counts than those with a single admission. These findings may suggest that phenotyping-including blood eosinophils-could help stratify the risk of recurrent severe exacerbations and personalised treatment.
Related
- Comorbidity Burden and Clinical Management Challenges in Severe Asthma: Insights from a Pan-European SHARP Study
- Multiple organic acid-rich fermented wheat bran improves duck meat quality: insights from physicochemical, sensory, and metabolomic properties
- Viral immune profiles in multiple sclerosis and HIV co-infection providing insights into antiretroviral treatment-associated immuno-remodeling
- Treatment of Severe Acute Graft-Versus-Host Disease Refractory to Multiple Lines of Therapy: Real-World Data from 317 Adults Treated with the Multiple-Donor Bone Marrow-Derived Mesenchymal Stromal Cell Preparation Tomostrocel
- Evaluating social cognitive remediation for labour participation in severe mental illness: insights from a small-scale randomised controlled trial
BibTeX
@article{ferre2026severe,
title = {{Severe COPD Exacerbators Requiring Multiple ICU Admissions Over Time: Insights of a French Cohort}},
author = {Alexis Ferré and Nassim Sahki and Pauline Puechoultres and Sylvain Diop and Georges Abi-Abdallah and Stéphane Legriel},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2026},
month = jun,
doi = {10.2147/copd.s613270},
url = {https://hal.science/hal-05750612v1},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Severe COPD Exacerbators Requiring Multiple ICU Admissions Over Time: Insights of a French Cohort
AU - Alexis Ferré
AU - Nassim Sahki
AU - Pauline Puechoultres
AU - Sylvain Diop
AU - Georges Abi-Abdallah
AU - Stéphane Legriel
PY - 2026
DA - 2026/06/18
JO - International Journal of Chronic Obstructive Pulmonary Disease
DO - 10.2147/copd.s613270
UR - https://hal.science/hal-05750612v1
AB - Introduction: Data on COPD patients who experience multiple intensive care unit (ICU) admissions for severe acute exacerbations (AECOPD) are scarce. We aimed to describe and compare patients' characteristics by recurrent admission status and to identify factors associated with recurrent ICU-level exacerbations. Methods: We conducted a single-centre, retrospective cohort study including all patients admitted to our ICU between 2015 and 2022 for a severe AECOPD. Patients with more than one ICU admission during the study period were classified as "recurrent exacerbator" phenotype. Multivariable regression and competing-risk models were used. Results: We included 328 patients who had a total of 445 admissions. Seventy-two (22.0%) patients had multiple ICU admissions. Compared with non-recurrent patients, recurrent exacerbators were younger (median 67 vs 70 years, p=0.037), had a lower prevalence of impaired Performance Status (13.9% vs 25.8%, p=0.035), and had higher blood eosinophil counts (0.06 vs 0.04 G/L, p=0.025). One-year mortality was similar between groups (18.1% vs 18.4%, p=0.95). In multivariate model, factors independently associated with recurrent severe exacerbation were long-term oxygen therapy (HR = 1.79, p=0.045) and initial blood eosinophil count (HR per +0.1 G/L = 1.10, p<0.001). A Performance Status ≥3 was inversely associated with recurrence (HR per point = 0.41, p=0.030). Conclusion: Patients with recurrent ICU admission for severe COPD exacerbations were younger and had higher blood eosinophil counts than those with a single admission. These findings may suggest that phenotyping-including blood eosinophils-could help stratify the risk of recurrent severe exacerbations and personalised treatment.
SN - 1176-9106
SN - 1178-2005
ER -